tirzepatide uric acid levels study Impact of oral semaglutide on serum urate in people with type 2 diabetes: A retrospective real-world analysis (URISEMA study) Hypertriglyceridemia is common and can

October 2025 : The Wegovy warning label was updated to include Severe Gastrointestinal Adverse Reactions in the WARNINGS AND PRECAUTIONS section

Always consult with your healthcare provider to decide how long to continue the medication or if you're considering stopping it

Aligned with earlier findings, semaglutide treatment at dosages from 0.5 mg to 2 mg weekly demonstrated variable efficacy, from merely preventing further weight gain in Patient 1 to achieving weight loss of up to 14.4% and 11% relative to baseline, in Patient 2 and Patient 3, respectively

GLP-1 medications can produce a 10-20% body weight reduction in many patients (ref), which can reduce the excess tissue mass that collapses the airway and causes OSA